The Northwest Regional Primary Care Association invites you
to submit an abstract proposal for consideration to present at the 19th
Annual Western Migrant Stream Forum.Click here
to download the abstract proposal form. The
deadline for submission is September 18, 2009.
The Western Migrant Stream Forum brings together a broad
representation of migrant health professionals for three days of education and
training, information and resource sharing, coalition building, and policy
development. Join us as we learn about current issues, policy, and
programs related to the healthof
migrant and seasonal farmworkers.
Please contact Seth Doyle, sdoyle@...;
(206) 783-3004 ext.16, with any questions.
Below
please find a recent notice from CDC on advice regarding separation of persons
with H1N1 from work and school environments, in anticipation of an upsurge of
the influenza in the fall cold and flu season.
As
critical providers of primary healthcare you may find this to be helpful
information as you plan your policies and response to the probability that your
centers will encounter the influenza among either or both your patient and
employee populations.
Bobbi
Ryder
Bobbi Ryder
President & CEO
National Center for Farmworker Health, Inc.
1770 FM 967
Buda, TX
(512) 312-5453 direct line
(512) 312-5451 Lisa Mendoza Miller, Assistant
(512) 312-2600
www.ncfh.org
From: Centers for Disease
Control & Prevention [mailto:cdc@...] Sent: Friday, August 07, 2009 8:55 AM To: ryder@... Subject: CDC Public Health Emergency Update: Health Alert Notice
DEPARTMENT
OF HEALTH & HUMAN
SERVICES Public
Health Service
Centers
for Disease Control
And
Prevention (CDC)
Atlanta, GA
30333
This notice is about the exclusion period, or the amount of
time persons should be away from others if they have Novel H1N1 Influenza.
You
are signed up to receive American Red Cross updates from CDC's Community
Health Outreach & Education Team (CHET). CHET is part of
CDC’s Emergency Communication System – an all-hazards response unit
with resources and structures to provide emergency information through appropriate
channels to multiple audiences across the country.
Please read
the important public health information below and send to your constituency as
you see fit.
This is an
official
CDC Health
Advisory
Distributed via Health Alert
Network
Month dd, 20yy,
13:51EDT (01:51PM EDT)
CDCHAN-00XXX-yy-mm-dd-ADV-N
CDC Updates
Recommendations for the Amount of Time Persons with Influenza-Like Illness
should be Away from Others
On August 5, 2009, CDC changed its recommendation related to the
amount of time people with influenza-like illness should stay away from others
(the exclusion period). New guidance indicates that people with influenza-like
illness should stay home for at least 24 hours after their fever is gone
(without the use of fever-reducing medicine). A fever is defined as having a
temperature of 100° Fahrenheit or 37.8° Celsius or greater.
This is a change from the previous recommendation that ill persons
stay home for 7 days after illness onset or until 24 hours after the resolution
of symptoms, whichever was longer.
The new recommendation applies to camps, schools, businesses, mass
gatherings, and other community settings where the majority of people are not
at increased risk for influenza complications. CDC
recommends this exclusion period regardless of whether or not antiviral
medications are used. This
guidance does not apply to health care settings where the exclusion
period continues
to be for 7 days from symptom onset or until 24 hours after the resolution of
symptoms, whichever is longer. (See http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm
for guidance on infection control in health care settings.)
Decisions about extending the exclusion period should be made at
the community level, in conjunction with local and state health officials. More
stringent guidelines and longer
periods of exclusion – for example, until complete resolution of all
symptoms – may be considered for people returning to a setting where high
numbers of high-risk people may be exposed.
This exclusion period guidance for the community setting is based
on epidemiologic data about the overall risk of severe illness and death. The
new recommendation attempts to balance the risks of acquiring illness from
influenza and the potential benefits of decreasing transmission through the
exclusion of ill persons with the goal of minimizing social disruption. This guidance will
continue to be updated as more information becomes available.
Health Alert conveys the highest level of
importance; warrants immediate action or attention.
Health Advisory provides important information for a
specific incident or situation; may not require immediate action.
Health Update provides updated information regarding
an incident or situation; unlikely to require immediate action.
##This Message
was distributed to State and Local Health
Officers, Public Information Officers, Epidemiologists and HAN Coordinators as
well as Clinician organizations##
You have received this message based upon the information
contained within our emergency notification data base. If you have a different
or additional e-mail or fax address that you would like us to use please contact your
State-based Health Alert Network program at your State or local health
department.
Located approximately 45 minutes from Philadelphia, PA, Southern Jersey Family Medical Center has 8 community and/or migrant health center. The Migrant Outreach Coordinator is responsible for planning, developing, and implementing the provision of health education, outreach, transportation, interpretation and social services to migrant and seasonal farmworkers in the South Jersey area during the harvest
season (approx. April – October), as well as to the community at large. The Outreach Coordinator will work with a team of 3-15 outreach specialist drivers. Openings at our Hammonton and Pemberton offices in New Jersey.
Job Category: Full time
Salary: $32,000+ (depending on experience) with benefits
Requirements: Graduation from a 4 year institution with a major in nursing,
health education, public health or related field. Bi-lingual Spanish and/or Haitian
Creole or Portuguese. Must have a valid driver’s license. Must have basic
computer skills and experience with MS Windows. Must be willing to work evenings
Monday-Thurs and some weekends.
Preferred: 1 to 2 years of managerial experience, Community Health
education or social service experience with farmworkers, CHES, LPN or RN.
Community needs assessment, focus group facilitation and program evaluation
experience. Knowledge of the South Jersey
area, organizations and needs is a plus. At least 26 years old in order to
drive a company vehicle.
I would like to share with you the attached article on an Intern with
the National Rural Health Association, Fiorella Horna Guerra. It is always
great to see positive press on the farmworker population….and Fiorella is
clearly an outstanding advocate.
This
article has been re-printed with permission from the National Rural Health Association.
Bobbi
Ryder
Bobbi
Ryder
President
& CEO
National
Center for Farmworker Health, Inc.
1770
FM 967
Buda,
TX
(512)
312-5453 direct line
(512)
312-5451 Lisa Mendoza Miller, Assistant
(512)
312-2600
www.ncfh.org
From: Lisa Miller
[mailto:miller@...] Sent: Monday, August 03, 2009 3:56 PM To: 'Ryder' Subject: NRHA Article for E-Groups
Bobbi,
PDF version of article attached
for distribution to e-groups. Permission to share below. Please
include the full organization name (National Rural Health Association) and
website (www.RuralHealthWeb.org) in
the postings, as
New publication: Arcury TA, Marín A, Snively BM, Hernández-Pelletier M, Quandt SA. Reducing farmworker residential pesticide exposure: evaluation of a lay health advisor intervention. Health Promotion Practice 10:447-455, 2009.
Your everyday outreach activities could be somebody else's
solutions! Share the creative ways you're serving farmworkers with your peers
in migrant health by submitting an Innovative Outreach Practice. Your submission will be considered for inclusion
in FHSI's 2010 Innovative Outreach Practices Report and M/CHCs and
Voucher Programs will be nominated for the Sister Cecilia B. Abhold
Award--which includes a cash prize!
For more information on guidelines, benefits of the Sister
Cecilia B. Abhold award, and previous practices submitted, visit http://farmworkerhealth.org.
Erin- while it is not an optimal option, there is also the possibility
of helping the person get back to their home country. In speaking to several
Mexican Consulates they have indicated that helping co-nationals return home is
a major element of their work portfolio. This may be the case with other
countries. If Gail is interested in having our Health Network staff work on
helping people get back to their country- with the person’s consent- this
is something we could do. It is a terrible circumstance and as I said not a
great option but one to consider. Best, Del
From:migrant_health_research@yahoogroups.com [mailto:migrant_health_research@yahoogroups.com] On Behalf Of Erin Sologaistoa Sent: Friday, July 24, 2009 10:53
AM To:migrant_health_research@yahoogroups.com Cc: maurerg@... Subject: [migrant_health_research]
End of life care for undocumented immigrants
Hi Everyone,
I am writing to
get ideas on a heartbreaking matter. I spoke to Gail Maurer today. She is the
Psychosocial/ Bereavement Director at HPC Healthcare Inc., a hospice
organization that serves Hillsborough, Highlands, Polk and HardeeCounties
in Florida.
She called to discuss the situation with undocumented immigrants in her
community. With some frequency undocumented patients are discharged from the
hospital or other inpatient facilities and have absolutely no place to stay, no
family, no home, nowhere. In many of these cases HPC has cared for the patients
at their facility until they made their transition. Of course, all hospice
patients are terminally ill. However, HPC is not really equipped to do this on
a regular basis and is looking for viable alternatives. With patients who have
Medicaid or other forms of insurance, they are able to place them in nursing
homes or other facilities, which will not accept undocumented immigrants
without insurance. County programs for the indigent also exclude undocumented
immigrants.
We discussed the
situation and came up with a few ideas, including getting the word out to the
community, where compassionate individuals might be willing to let these people
stay with them until they die. Another idea but longer term is to write a grant
to fund some of their care. I told her I would send an email to my contacts and
see if others have had experience with this or have ideas about possible
solutions. It is so sad to think of someone being so alone at the end of their
life. Please let us know if you have experience with this, or other ideas about
how to address the situation. Gail’s contact info is below and I have
copied her on this email. I would appreciate being kept in the loop so I can
learn more about this.
I am writing to get ideas on a heartbreaking matter. I spoke to Gail
Maurer today. She is the Psychosocial/ Bereavement Director at HPC Healthcare
Inc., a hospice organization that serves Hillsborough, Highlands, Polk and HardeeCounties
in Florida.
She called to discuss the situation with undocumented immigrants in her
community. With some frequency undocumented patients are discharged from the
hospital or other inpatient facilities and have absolutely no place to stay, no
family, no home, nowhere. In many of these cases HPC has cared for the patients
at their facility until they made their transition. Of course, all hospice
patients are terminally ill. However, HPC is not really equipped to do this on
a regular basis and is looking for viable alternatives. With patients who have
Medicaid or other forms of insurance, they are able to place them in nursing
homes or other facilities, which will not accept undocumented immigrants
without insurance. County programs for the indigent also exclude undocumented
immigrants.
We discussed the situation and came up with a few ideas, including
getting the word out to the community, where compassionate individuals might be
willing to let these people stay with them until they die. Another idea but
longer term is to write a grant to fund some of their care. I told her I would
send an email to my contacts and see if others have had experience with this or
have ideas about possible solutions. It is so sad to think of someone being so
alone at the end of their life. Please let us know if you have experience with
this, or other ideas about how to address the situation. Gail’s contact
info is below and I have copied her on this email. I would appreciate being
kept in the loop so I can learn more about this.
You said: "Ron, its usually minimum wage with no benefits. Depending on state
they live in."
Actually, that's not true. As the information I just posted shows the average
wage in the US is $10.84 an hour. In many states, like NYS, those "no benefits"
typically include free housing and all that it entails, including gas & electric
and in many cases, like on my farm, free DirectV service.
As one source states:
"Farmworkers in the US are offered a range of services - supported by federal,
state and local government, as well as by non-profits, community organizations,
churches and individuals…. Other services that cater to migrant farmworkers
include: pesticide training, day care, legal services, immigration counseling,
English classes, substance abuse programs, WIC, Medicaid, job training, job
placement, housing, domestic violence counseling, women's groups, high school
equivalency programs, soccer leagues, recreation, arts programs and emergency
services."
http://www.whyhunger.org/news-and-alerts/47-why-speaks/508-serving-farmworkers.h\
tml
Farmworkers in New York benefit from a number of governmentally funded social
service programs that, in many cases, only exist for their benefit, including
their own FREE government funded health clinics, day care centers for their
children (now 14 throughout the state), federally funded migrant education
programs, as well as their own government funded law firm which works only in
their behalf.
Is it the "Life of Riley/" No. But it's hardly minimum wage with no benefits
either.
C.
--- In migrant_health_research@yahoogroups.com, "Rene J. Quintana"
<rquintana@...> wrote:
>
> Ron, its usually minimum wage with no benefits. Depending on state they live
in.
>
> Mr. Rene Quintana
> From: migrant_health_research@yahoogroups.com
[mailto:migrant_health_research@yahoogroups.com] On Behalf Of Ron Strochlic
> Sent: Wednesday, July 22, 2009 6:13 PM
> To: migrant_health_research@yahoogroups.com
> Subject: [migrant_health_research] "real" farmworker wages
>
>
>
> Can anyone point me to information on "real" farmworker wages - i.e.
> adjusted for inflation - as compared with past wages. I'm not looking
> for a specific point in time, so any information will be appreciated.
>
> Thanks,
>
> Ron Strochlic
> Executive Director
> California Institute for Rural Studies
> 221 G Street, Suite 204
> Davis, CA 95616
> office: 530-756-6555 x16
> www.cirsinc.org
>
Statistics for farmworker wages, and hours, broken up by regions can be found
here:
This link are for the current figures:
http://usda.mannlib.cornell.edu/usda/current/FarmLabo/FarmLabo-05-22-2009.txt
This link you can see historical wages:
http://usda.mannlib.cornell.edu/MannUsda/viewDocumentInfo.do?documentID=1063
Hope this helps.
C.
--- In migrant_health_research@yahoogroups.com, Ron Strochlic <rstrochlic@...>
wrote:
>
> Can anyone point me to information on "real" farmworker wages - i.e.
> adjusted for inflation - as compared with past wages. I'm not looking
> for a specific point in time, so any information will be appreciated.
>
> Thanks,
>
>
> Ron Strochlic
> Executive Director
> California Institute for Rural Studies
> 221 G Street, Suite 204
> Davis, CA 95616
> office: 530-756-6555 x16
> www.cirsinc.org
>
Ron, its usually minimum wage with no benefits. Depending
on state they live in.
Mr. Rene Quintana
From:
migrant_health_research@yahoogroups.com
[mailto:migrant_health_research@yahoogroups.com] On Behalf Of Ron
Strochlic Sent: Wednesday, July 22, 2009 6:13 PM To: migrant_health_research@yahoogroups.com Subject: [migrant_health_research] "real" farmworker wages
Can anyone point me to information on
"real" farmworker wages - i.e.
adjusted for inflation - as compared with past wages. I'm not looking
for a specific point in time, so any information will be appreciated.
Thanks,
Ron Strochlic
Executive Director
California Institute for Rural Studies
221 G Street, Suite 204
Davis, CA 95616
office: 530-756-6555 x16
www.cirsinc.org
Marín A, Carrillo L, Arcury TA, Grzywacz JG, Coates ML, Quandt SA. Ethnographic Evaluation of a Lay Health Promoter Program to Reduce Occupational Injuries among Latino Poultry Processing Workers. Public Health Reports 124 (supplement 1):36-43, 2009.
Can anyone point me to information on "real" farmworker wages - i.e.
adjusted for inflation - as compared with past wages. I'm not looking
for a specific point in time, so any information will be appreciated.
Thanks,
Ron Strochlic
Executive Director
California Institute for Rural Studies
221 G Street, Suite 204
Davis, CA 95616
office: 530-756-6555 x16
www.cirsinc.org
Dear Colleagues,
On May 12th, 2009 the National Center for Farmworker Health unveiled the
2009 commemorative artwork at the National Farmworker Health Conference in
San Antonio, TX. Please check out the attachment to this email to see
this beautiful image which is currently available at the conference rates of
$35.00 for the poster with commemorative graphics and $200 for the fine art
print. Proceeds of all sales provide academic scholarships to Migrant
Health Center Staff.
This artwork is entitled Trabajo y Tarea and was created by Ramiro
Rodriguez. Mr. Rodriguez was born to Mexican emigrants and grew up in
Western Michigan. He currently lives in South Bend, Indiana with his wife
and two sons. He is an Exhibition Coordinator at the Snite Museum of Art at
the University of Notre Dame. Prior to arriving at Notre Dame, he worked as
an exhibition preparator at the Cincinnati Art Museum and the Contemporary
Arts Center in Cincinnati, Ohio. He has taught painting and drawing classes
at the University of Cincinnati, Miami University and the Art Academy of
Cincinnati. Mr. Rodriguez's figurative paintings and prints have been
exhibited and have won awards in various one-person and group shows around
the country. His works are included in numerous private collections around
the world. He is a member of the Consejo Grafico, an independent network of
Latino print workshops formed to advance the legacy and viability of Latino
printmaking in the United States. Mr. Rodriguez has encountered the widest
public recognition through the reproduction of his works by the
multi-platinum selling musical group Tool. The group's use of several of
Mr. Rodriguez's images for promotional material has introduced his work to
many music fans around the world.
The proceeds of sales of the 2009 Commemorative Artwork benefit the NCFH
Migrant Health Scholarship Fund and awards will be made next year based on
the volume of sales from this year. Scholarship awards are given to
individuals who are currently employed by community / migrant health centers
and have decided to advance their education academically and recommit to
migrant health as their career choice. Awards represent a variety of health
professions, disciplines and backgrounds. If you would like to purchase the
2009 artwork in poster form or as a limited edition art print you can do so
by filling going to http://www.ncfh.org/index.php?pid=8 or by contacting
Josh Shepherd at shepherd@... or by phone at (512) 312-5463.
Bobbi Ryder
Bobbi Ryder
President & CEO
National Center for Farmworker Health, Inc.
1770 FM 967
Buda, TX
(512) 312-5453 direct line
(512) 312-5451 Lisa Mendoza Miller, Assistant
(512) 312-2600
www.ncfh.org
Please forward widely. Registration (Early Bird Rate) and Abstract Submission Now Open.
Global Health & Innovation Summit The World's Leading Idea Incubator For Global Health Innovation
A Conference Presented Annually by Unite For Sight Yale University, New Haven, Connecticut, USA
Saturday, April 17 - Sunday, April 18, 2010 Registration Now Open (Early Bird Registration Rate):http://www.uniteforsight.org/conference
Call For Abstracts: Submit an abstract online at http://www.uniteforsight.org/conference The first deadline for abstract submission is August 15, and the final abstract deadline is September 20.
"A Meeting of Minds," --CNN
200 Speakers in April 2010, Including Keynote Addresses by Seth Godin, Jeffrey Sachs and Sonia Sachs. Plus social innovation sessions by CEOs and Directors of Acumen Fund, Partners in Health, WaterPartners, Save The Children, HealthStore Foundation, and many others.
The Global Health & Innovation Summit convenes more than 2,200 participants from 55 countries. The Summit challenges students, public health professionals, educators, doctors, scientists, lawyers, universities, corporations, nonprofits, and others, to develop innovative, effective solutions to achieve global goals.
Keynote Speakers
"Using The Power of Stories and Tribes to Spread Your Messages and Change The World," Seth Godin, MBA, Agent of Change; New York Times Bestselling Author of Tribes: We Need You To Lead Us; Founder, Squidoo.com
Jeffrey Sachs, PhD, Director of Earth Institute at Columbia University; Quetelet Professor of Sustainable Development, Professor of Health Policy and Management, Columbia University; Special Advisor to Secretary-General of the United Nations Ban Ki-moon
Sonia Ehrlich Sachs, MD, MPH, Health Coordinator, Millennium Village Project
Leaders of Social Innovation and Social Entrepreneurship Speakers
Scott Hillstrom, Chairman of the Board, CEO and Co-Founder, HealthStore Foundation
Kevin Jones, Co-Founder, Good Capital
Nancy Lublin, CEO, Do Something
Nicholas Lumpp, Cofounder, Somaly Mam Foundation
Joia Mukherjee, MD, MPH, Medical Director, Partners in Health; Director, Institute for Health and Social Justice; Assistant Professor, Harvard Medical School; Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital
Ajay Nair, MBBS, MPH, Portfolio Associate, Acumen Fund
Billy Shore, JD, Founder and CEO, Share Our Strength
Kevin Starr, MD, Rainer Arnhold Fellows Program, Mulago Foundation
Gary White, Executive Director, WaterPartners
Andrew Wolk, CEO, Root Cause
Plus 200 Featured Speakers, including:
Ron Adelman, MD, MPH, Associate Professor of Ophthalmology, Yale University Eye Center
Jesus Aguais, Executive Director, Aid for AIDS
Astier Almedom, DPhil, Professor of Practice in Humanitarian Policy and Global Public Health
Agbessi Amouzou, PhD, Assistant Scientist, Institute for International Programs, Johns Hopkins Bloomberg School of Public Health
Tom Arnold, CEO, Concern Worldwide
Jane Aronson, MD, Director, International Pediatric Health Services; Founder and Executive Officer, Worldwide Orphans Foundation (WWO); Clinical Assistant Professor of Pediatrics, Weill Medical College of Cornell University
Bob Bollinger, MD, MPH, Professor of Infectious Diseases and International Health; Director, Center for Clinical Global Health Education, Johns Hopkins University
Peter Bourne, MA, MD, Visiting Scholar, Oxford University; Vice Chancellor Emeritus, St. George's University; Formerly Special Assistant to the President of the United States for Health Issues; Chair, Medical Education Cooperation with Cuba (MEDICC)
Kathleen Casey, MD, FACS, Director, Operation Giving Back, American College of Surgeons
James Clarke, MD, Ophthalmologist and Medical Director, Crystal Eye Clinic, Ghana
Luz Claudio, MD, Associate Professor of Community and Preventive Medicine, Chief of the Division of International Health, Mount Sinai School of Medicine
Paul Cleary, PhD, Dean of Public Health, Chair, Epidemiology and Public Health; Anna M.R. Lauder Professor of Public Health, Yale University School of Public Health
Gustavo V. de Moraes, MD, Research Assistant Professor, NYU School of Medicine, Department of Ophthalmology, New York Eye and Ear Infirmary
Prabhjot Dhadialla, PhD, Program Director of Health Systems, Development and Research, Columbia Center For Global Health and Economic Development, Community Health Worker Advisor, Millennium Village Project
Zoravar Dhaliwal, CEO, Community Lab
Amir Dossal, Executive Director, UN Office for Partnerships
Margaret Duah-Mensah, RN, ON, Ophthalmic Nurse, Crystal Eye Clinic, Ghana
Harvey Fineberg, MD, PhD, President, Institute of Medicine of The National Academies
Susan Forster, MD, Associate Clinical Professor, Department of Medical Studies, Department of Ophthalmology, Yale School of Medicine; Chief, Ophthalmology, Yale University Health Services
Kevin Frick, PhD, Associate Professor, Johns Hopkins Bloomberg School of Public Health
Pape Gaye, President and CEO, IntraHealth International
Ilene Gipson, PhD, Senior Scientist, Schepens Eye Research Institute; Professor, Department of Ophthalmology, Harvard Medical School
Ashifi Gogo, Co-founder, Sproxil; Holekamp Family PhD Innovation Fellow, Thayer School of Engineering at Dartmouth
Kate Grant, Executive Director, The Fistula Foundation
Laura Herman, Managing Director, Social Impact Advisors
Christopher P. Howson, PhD, Vice President for Global Programs, The March of Dimes Foundation
Marcelo Jacobs-Lorena, PhD, Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins School of Public Health
Kaveh Khoshnood, PhD, Assistant Professor in P®Ö.rö²lŽefý¶öTr$Is'Œ¬µ“ù‰„DfÍ DÕ®Ãx::ŒíÑ{ÂF¯6@®°ÛQ€ *q—ëÅiéD3 School of Public Health
Norman Kleiman, PhD, Director, Eye Radiation and Environmental Research Laboratory, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University
Jamie Lachman, Clowns Without Borders
Robert Lawrence, MD, The Center for a Livable Future Professor, Professor of Environmental Health Sciences, Health Policy, and International Health; Director, Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health
Ted London, PhD, Senior Research Fellow; Director, Base of the Pyramid Initiative, William Davidson Institute at the University of Michigan
Pamela Lynam, MD, Country Director Kenya, JHPIEGO - Johns Hopkins University
John McGoldrick, JD, Senior Vice President, International AIDS Vaccine Initiative (IAVI)
Carole Mitnick, Sc.D., Instructor, Department of Global Health and Social medicine, Harvard Medical School
Mini Murthy, MD, MPH, MS, MPhil, CHES, Assistant Professor, Department of Health Policy and Management, Global Health Program Director, New York Medical College School of Public Health
Ron Nabors, Chief Executive Officer, Christian Blind Mission-USA
Cliff O'Callahan, MD, PhD, FAAP, Pediatric Faculty, Family Practice Group; Director of Nurseries, Middlesex Hospital; Chair, AAP Section on International Child Health
Rebecca Onie, JD, Co-Founder and Chief Executive Officer, Project HEALTH
Santa Ono, PhD, Sr. Vice Provost for Undergraduate Education and Academic Affairs, Emory University
David Oot, Associate Vice President for Health, Save The Children
Sung Chul Park, MD, Glaucoma Fellow, New York Medical College, New York Eye and Ear Infirmary
Matthew Paul, MD, Danbury Eye Physicians and Surgeons
Steven Phillips, MD, Medical Director, Global Issues and Projects, ExxonMobil Corporation
Maryse B. Pierre-Louis, MD, MPH, MH/HSA, Lead HNP Specialist, Human Development; Coordinator, Booster Program For Malaria Control in Africa, World Bank Africa Region
Louis Pizzarello, MD, MPH, Secretary General, International Agency for the Prevention of Blindness
Suzanne Rainey, Forum One Communications
Rebecca Richards-Kortum, PhD, Stanley C. Moore Professor and Chair of Bioengineering, Rice University
Majid Sadigh, MD, Assistant Clinical Professor, Internal Medicine, Yale School of Medicine
Sarwat Salim, MD, Assistant Professor of Ophthalmology, University of Tennessee-Memphis
Georgia Sambunaris, Senior Advisor to the Director, Office of Economic Growth, US Agency for International Development
David Spiegel, MD, Children's Hospital of Philadelphia; Assistant Professor, University of Pennsylvania School of Medicine
Laura Stachel, MD, Bixby Center for Reproductive Health, UC Berkeley School of Public Health
John E. Tedstrom, PhD, President and CEO, Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC)
James C. Tsai, MD, Robert R. Young Professor and Chairman, Department of Ophthalmology and Visual Sciences, Yale University School of Medicine; Chief of Ophthalmology, Yale-New Haven Hospital
Sheila West, PhD, El-Maghraby Professor of Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins School of Medicine
David Zakus, BSc, MES, MSc, PhD, Director, Centre for International Health; Associate Professor, Dalla Lana School of Public Health; Associate Professor, Department of Health Policy, Management and Evaluation; Faculty of Medicine, University of Toronto, Canada
Derek Yach, Vice President of Global Health Policy, PepsiCo
Rear Adm. Tim Ziemer, U.S. Malaria Coordinator, President's Malaria Initiative
It’s not too late to join us for tomorrow’s webcast on
Maximizing Farmworker Involvement in Board Governance. We look
forward to seeing you there tomorrow!
Maximizing Farmworker Involvement in
Board Governance
A LIVE WEBCAST PRESENTED BY:
Roberta Ryder National Center for Farmworker Health
Deliana Garcia Migrant Clinicians Network
SUMMARY
The
health and well being of the migrant and community health center ultimately
lies with the board of directors of the corporation. This presentation
discusses the interface between the clinical, governance and management of
health centers with a particular focus on the role of the board of directors.
Long the prevue of the Executive Director, identification of potential board
members has rarely extended beyond executive staff and the other members of
the board. However, clinic staff, particularly providers, may be excellent
sources for identifying interested and competent consumers that would be good
candidates. This session will discuss some of the challenges and strategies
for success in identifying and recruiting strong consumer board members. The
use of case-based teaching will provide real world examples of successful and
problematic recruitment of board members.
Learning
Objectives:
1. Participants will identify at least three major
challenges to successfully working with farmworker consumer board members.
2.Participants will discuss how technology can be used to more
successfully work with farmworker board member.
3.Participants will examine two case studies and identify the
decision points that led to either a success or a breakdown in health center
board governance.
Last
week I sent you an introductory email about Consumer Reports’ Best Buy
Drug program. I hope that you found the time to look it over and
determine if it might be of use to you and your staff.
Here
is a second email which will direct you to their web site for general
information on the program and to sign up for their monthly newsletter.
Sign up for Best Buy Drug
free newsletter
http://www.consumerreports.org/cro/customer-service/email-service/e-mail-newsletters/index.htm)
so that you can stay informed about all of the updates.
Here
is the latest from CDC on the H1N1Influenza. FYI¡Ä.
Bobbi Ryder
President & CEO
National Center for Farmworker Health, Inc.
1770 FM 967
Buda, TX
(512) 312-5453 direct line
(512) 312-5451 Lisa Mendoza Miller, Assistant
(512) 312-2600
www.ncfh.org
FluView
Influenza Activity Update
·Influenza
illness, including illness associated with the pandemic influenza A (H1N1)
virus, is ongoing in the United States.
·As of June 19,
2009, 21,449 confirmed and probable infections with pandemic influenza A (H1N1)
virus have been identified by CDC and state and local public health departments
with 87 deaths.
·During week 23
(June 7 – 13, 2009), the June 19 FluView Report shows that influenza
activity overall decreased in the United States; however, there are still
higher levels of influenza-like illness than is normal for this time of year
and pandemic H1N1 outbreaks are ongoing in parts of the United States, in some
cases with intense activity.
·11 states in
the U.S. are reporting widespread influenza activity (Arizona, Connecticut, Delaware,
Hawaii, Maine, New Jersey, New York, Pennsylvania, Rhode Island, Utah, and Virginia);
6 states and Puerto Rico are reporting regional influenza activity; 13 states
and the District of Columbia are reporting local influenza activity; and 20
states are reporting sporadic activity.
·It is very
unusual for this time of year to still be having so many states reporting
regional and widespread activity.
·Pandemic H1N1
viruses now make up approximately 98% of all subtyped influenza A viruses
analyzed by the U.S. WHO/NREVSS collaborating laboratories.
·Overall, the
nationwide level of outpatient visits to providers for influenza-like-illness
is below the national baseline, but one of the 10 surveillance regions reported
an influenza-like illness percentage above its region-specific baseline (Region
II).
oThis was in Region II, which includes New Jersey,
New York, Puerto Rico, and the U.S. Virgin Islands.
oIncreases in ILI in region
II likely represent an increase in influenza activity in large cities in that
region, such as New York City, which is experiencing community outbreaks of
pandemic H1N1.
·Influenza-like
illness decreased during week 23 in six of 10 regions compared to week 22.
·The proportion
of deaths attributed to pneumonia and influenza (P&I) was slightly above
the epidemic threshold.
·One
influenza-associated pediatric death was reported and was associated with
pandemic influenza A (H1N1) virus infection during Week 23.
·Since September
28, 2008, CDC has received 71 reports of laboratory confirmed
influenza-associated pediatric deaths that occurred during the 2008-09
influenza season, six of which were due to pandemic influenza A (H1N1) virus
infections.
·It¡Çs uncertain
at this time how severe this H1N1 pandemic will be in terms of how many people
infected will have severe complications or death from pandemic H1N1-related
illness.
·It is likely
that localized outbreaks will continue to occur over the summer and that we
will see pandemic H1N1 virus, illness and death during the upcoming U.S. flu
season in the fall and winter.
·The real
uncertainty is how widespread and severe the pandemic H1N1 virus will be during
the 2009-2010 influenza season in the United States.
·We are still
learning about the severity and other epidemiological characteristics of the
pandemic H1N1 virus and are watching the Southern Hemisphere very carefully to
see how pandemic H1N1 affects their influenza season, which is just beginning.
·This
information is important and will be taken into account when making
recommendations with regard to vaccine and other preventive measures in the
fall.
Enhanced
Influenza Surveillance in the Southern Hemisphere
·The Centers for
Disease Control and Prevention (CDC) is working closely with countries in the
Southern Hemisphere to enhance surveillance for influenza viruses circulating
in the Southern Hemisphere, including pandemic H1N1 flu.
The Southern
Hemisphere is just going into its flu season now and how this virus
behaves will give us some clues about what we can expect for the Northern
Hemisphere.
·CDC is providing
real-time, reverse transcriptase polymerase chain reaction (rRTPCR) reagents to
all national influenza centers (NICs) in the Southern Hemisphere region and is
working with the Pan American Health Organization (PAHO)* to increase
laboratory testing capacities in South/Central America by supplying resources
and training.
* PAHO is a regional
office of the World Health Organization (WHO).
·In addition, CDC is providing to all NICs in the PAHO region a
supplemental WHO Influenza kit containing reagents for identification of
pandemic H1N1 influenza virus in the Hemagglutination Inhibition (HI) assay.
·CDC's
Influenza Division has provided the necessary
documents and forms with instructions for sending influenza virus isolates and
specimens to CDC to 28 NICs in PAHO.
·As part
of CDC¡Çs efforts to enhance surveillance in the Southern Hemisphere, CDC has
developed guidance for national laboratories within PAHO to send their most
recent and representative
influenza virus isolates to CDC more frequently: as often as every two weeks,
if possible.
·The
World Health Organization has offered to help countries ship influenza virus
isolates and specimens to CDC for testing by
supplying financial and logistical support.
·In addition to laboratory assistance, CDC has deployed two
epidemiologists, one to Peru and one to Chile, to assist with planning enhanced
surveillance activities.
·A recent mission to Chile, Argentina, and Bolivia has met with the
ministries of health in each of those countries to map out a strategy for
enhancing surveillance.
·CDC has provided $200,000 (U.S. Dollars) to the Central America
Project in Guatemala to enhance surveillance for severe acute respiratory
illness in five countries of Central America.
Summer Camp Guidance
·CDC has heard
reports of pandemic H1N1 outbreaks in summer camps in the U.S.
·This is not
surprising given the fact that children and young adults have been the most
affected by the outbreak of pandemic H1N1 flu so far.
·CDC has developed
guidance for day and residential camps in response to human infections with
pandemic H1N1 influenza and posted this information on our website.
·It is important
that camp staff members, parents and others are aware of, and use measures to
protect themselves and also the public¡Çs health by making plans for how to
prevent and control outbreaks in camps and other places that children and young
adults gather.
·CDC is recommending
that the primary way to reduce spread of influenza in camps is to focus on identifying
ill campers and staff as soon as possible, moving ill persons away from well
campers, treating ill campers, educating campers and staff about good
cough and hand hygiene etiquette, and educating camp facilitators and
administrators about environmental controls that should be in place to
encourage use of these practices.
·CDC is recommending
that people who currently have or have had influenza-like symptoms in the
previous seven days should not attend, work or volunteer in a camp until at
least seven days AFTER their symptoms began or until they have been
symptom-free for 24 hours, whichever is longer.
·Camp staff,
volunteers, and campers should be aware of the symptoms of pandemic H1N1 flu
and rapidly report to camp staff if they recognize any of them in campers or
themselves.
·CDC is encouraging
camp administrators and facilitators to work with parents to plan ahead for
what to do in the event that their child becomes ill while at camp.
·Camps should work
with local public health authorities to develop plans for addressing potential
camp outbreaks and establish an open line of communication.
·Hand washing
facilities, including running water and soap, should be available to all
campers and staff. Everyone should be reminded to use good hand hygiene (hand
washing and appropriate use of alcohol-based gels) and good cough etiquette
(covering coughs and sneezes).
·Aspirin or
aspirin-containing products should not be given to any person 18 years old or
younger with a confirmed or suspected case of influenza, due to the risk of
Reye¡Çs syndrome.
MMWR:
Novel H1N1 virus infections among healthcare personnel
On June 19, 2009 the Morbidity
and Mortality Weekly Report (MMWR) published a report entitled ¡ÈNovel
Influenza A (H1N1) Virus Infections Among Healthcare Personnel ¨¡ United States, April – May 2009¡É
As of May 13, 2009, CDC had received
information on 48 confirmed or probable pandemic H1N1 infections reported
to have occurred in people who worked in the healthcare profession; 26
with detailed information.
Of the 26 cases, CDC found
that:
o13 healthcare
personnel (HCP) (50%) were deemed to have acquired infection in a healthcare
setting which could have been from provider-to-provider (1) contact or
patient-to-provider (12) contact.
o11 healthcare
workers (42%) were deemed to have been infected in the community.
o2 HCP (8%) had no
reported exposures in either healthcare or community settings.
Two infected HCP were
hospitalized, one of whom reported underlying medical conditions. Neither
hospitalized HCP was admitted to the intensive care unit; neither died.
None of the HCP with potential
patient-to-provider transmission of pandemic H1N1 influenza reported
adhering to all recommended infection control practices for all contacts
with possible source patients.
These findings cannot
definitely establish whether these instances of patient-to-provider
transmission were related to non-adherence to certain parts of personal
protection equipment.
Whatever the risk of infection
to HCP, this report suggests that much of it exists in the outpatient
setting, such as outpatient clinics and emergency rooms.
Current CDC infection control
recommendations for the care of patients with pandemic H1N1 infections
include:
oAdministrative
actions such as exclusion of ill HCP from work
oThe use of
fit-tested N-95 respirators
oEye protection
oUse of gloves and
gowns
oAerosol-generating
procedures should be performed in an airborne infection isolation room with
negative pressure air handling
HCP were defined as employees,
students, contractors, clinicians or volunteers whose activities involved
contact with patients in a healthcare or laboratory setting.
These case reports do not
contain enough information to determine effectiveness of specific types of
personal protection equipment to protect against infection of pandemic
H1N1 infection.
WHO Declaration Phase 6
·On June
11, 2009, the World Health Organization (WHO) raised the worldwide pandemic
alert level to Phase 6.
Designation of
this phase indicates that a global pandemic is underway.
·There are now
community level outbreaks ongoing in other parts of the world.
·While U.S.
influenza surveillance systems indicate that overall flu activity is decreasing
in the United States, pandemic H1N1 outbreaks are ongoing in different parts of
the U.S., in some cases with intense activity.
·In the United
States, this virus has been spreading efficiently from person-to-person since
April and, as we have been saying for some time, we do expect that we will see
more cases, more hospitalizations and more deaths from this virus.
·Because there
is already widespread pandemic H1N1 disease in the United States, the WHO Phase
6 declaration does not change what the United States is currently doing to keep
people healthy and protected from the virus.
·Thus, there is
no change to CDC¡Çs recommendations for individuals and communities.
·WHO¡Çs decision
to raise the pandemic alert level to Phase 6 is a reflection of epidemiological
changes in other parts of the world and not a reflection of any
change in the pandemic H1N1 virus or associated illness.
·At this time,
most of the people who have become ill with pandemic H1N1 in the United States
have not become seriously ill and have recovered without hospitalization.
·In the United
States, we have been preparing for this for some time.
·And we are
actively and aggressively implementing our pandemic response plan.
Phase
6 is an indicator of spread and not of severity.
·It¡Çs uncertain
at this time how serious or severe this pandemic H1N1 pandemic will be in terms
of how many people infected have severe complications or death related to
pandemic H1N1 infection.
There were
three influenza pandemics in the last century and they varied widely in
severity.
The 1918
pandemic killed tens of millions of people.
The 1957
pandemic is thought to have resulted in at least 70,000 deaths in the United
States.
Deaths from
the 1968-69 pandemic were about the same as for seasonal influenza.
This pandemic
certainly poses the potential to be at least as serious as seasonal flu,
if not more so.
Because this
is a new virus, many people will not have immunity to it and illness may
be more severe and widespread as a result.
We are still
learning about this virus and expect that, like all influenza viruses, it
will continue to change.
We are taking action:
The Federal
Government is mounting an aggressive response to this newly declared
pandemic.
CDC¡Çs goals
during this public health emergency are to reduce transmission and illness
severity, and provide information to assist health care providers, public
health officials and the public in addressing the challenges posed by this
newly identified influenza virus.
·Everyday, we
learn more about this virus and what we learn will continue to inform the
actions that we take in response.
·We are
aggressively taking early steps in the vaccine manufacturing process, working
closely with manufacturing and the rest of the government.
·Vaccines are a
very important part of a response to pandemic influenza.
·CDC isolated
the pandemic H1N1 virus, made a candidate vaccine
·virus, and has
provided this virus to industry so they can begin scaling up for production of
a vaccine, if necessary.
·There are many
steps involved with producing a vaccine and we are committed to going forward
with the NIH, and FDA, BARDA, and the manufacturers of influenza vaccines, to
see about developing full scale vaccine production.
·Where possible,
we are taking parallel steps to speed up the vaccine process.
If
things go well, and we develop a full scale production, it would be
several months until the vaccine were available.
So
vaccine is an important tool for the future.
Pandemic Severity
·Influenza
pandemics can range in severity, mainly in terms of the number of people that
have severe illness and die.
·Pandemic
severity may also change over time and will differ across regions of the world,
in different countries and even within different communities within a country.
·Pandemic
disease severity will vary depending on several factors: a nation¡Çs ability to
provide health care to their people, the availability of antiviral medications
to treat those who are sick, differences in how the disease affects people in
different age groups, and the effectiveness of efforts to reduce
person-to-person transmission of influenza.
·An
evaluation of pandemic severity should be based on local circumstances for this
reason.
·A
pandemic severity index helps pubic health officials to match the timing of the
spread and severity of the outbreak with the appropriate use of public health
and community resources to minimize the number of people who get sick and the
number of people who die.
WHO has a
three point scale to determine pandemic severity: mild, moderate and
severe.
At this time,
WHO has indicated this seems to be a moderately severe pandemic.
U.S. Pandemic Severity Index (PSI)
CDC developed
the U.S. Pandemic Severity Index (PSI) to describe the severity of a
pandemic in terms of illness and death.
The U.S. PSI
scale is based on the case-fatality ratio; the likelihood of people dying
from the disease.
The PSI scale
ranges from Category 1 to Category 5 and is comparable to the U.S.
hurricane severity index.
Category 1 is
the least severe and Category 5 is the most severe.
·At the current
time, CDC estimates that the pandemic situation in the U.S. would be equivalent
to a pandemic severity index of 2. (This would be most similar to the 1957
influenza pandemic, however, it¡Çs uncertain how the current situation will
evolve over the coming months so it¡Çs not possible to make a predication about
deaths at this time.)
CDC
will re-evaluate the classification of the Pandemic Severity Index should
there be evidence that the pandemic has become more severe.
The
PSI will be adjusted based on that evaluation and appropriate guidelines
and recommendations provided.
CDC emphasizes that unnecessary weight
not be given to the numeric categorization of the pandemic.
According to
the U.S. PSI:
A category 1
pandemic has the following:
Case
fatality ratio of less than 0.1 percent
Excess death
rate of less than 30 per 100,000 people
Illness rate
of 20-40% of the population
Less than
90,000 potential deaths (based on 2006 U.S. population)
Similar to a
more severe seasonal flu year in the United States
A category 2
pandemic has the following:
¡øCase
fatality ratio of 0.1 percent to less than 0.5 percent.
¡øBetween
90,000 and 450,000 deaths in the U.S. (based on 2006 U.S. population)
¡øExcess
death rate of between 30 to less than 150 per 100,000 people
¡øIllness
rate of between 20 and 40 percent.
¡øSimilar
to 1957 pandemic.
A category 5
pandemic has the following:
Case
fatality ratio of greater or equal to 2 percent
Excess death
rate of more than 600 per 100,000 people
Illness rate
of 20-40% of the population
Greater than
or equal to 1.8 million potential deaths (based on 2006 U.S. population)
Similar to
the 1918 pandemic
The importance of identifying a
category of severity is only to help guide the public health interventions
recommended for individuals and communities.
The PSI scale
helps public health officials match the range of public health
intervention efforts to the severity of a pandemic.
For
a Category 1 to 3 pandemic:
Ill adults
and children are asked to stay home voluntarily.
If someone
in the household is sick, well adults and children do not need to
stay at home.
School and
child care dismissal is not generally recommended, but may be considered
depending on the local impact of the disease.
Workplace and Community adult social distancing
efforts (e.g., encouraging teleconferences instead of meetings, reducing
density, meaning the number of people crowded into an enclosed space, in
public transit and the workplace, postponing or canceling selected
public gatherings, encouraging people to telework, or take staggered
shifts) are generally not recommended.
For a
Category 4 to 5 pandemic
Ill adults
and children are asked to stay home voluntarily.
If someone
in the household is sick, well adults and children should stay at home
too.
School and
child care dismissal is recommended for up to 12 weeks.
Workplace and Community adult social distancing
efforts (e.g., encouraging teleconferences instead of meetings, reducing
density, meaning the number of people crowded into an enclosed space, in
public transit and the workplace, postponing or canceling selected
public gatherings, encouraging people to telework, or take staggered
shifts) are recommended
Declaration of Phase 6 and Travel
At this time,
CDC does not recommend against travel to any country.
CDC will
continue to monitor the pandemic H1N1 situation around the world and will
provide recommendations to U.S. travelers based on the changing situation.
Travelers
should check the CDC travelers¡Ç health website (www.cdc.gov/travel) for
information related to this outbreak, as well as for health information on
the prevention and management of flu.
Travelers
should also check the website of the embassy of the country to which they
are traveling for the latest updates on entry or exit screening procedures
which may impact their travel.
CDC recommends
that ill persons postpone travel both for their protection and that of
other travelers.
Public:
So
far, most people who have been ill with this virus have recovered.
We
are monitoring hospitalization and death rates.
At
this point, whether you are tested and actually diagnosed with pandemic
H1N1 is less important than what you do if you become sick.
It¡Çs
possible that this summer, people around you may get sick and you may get
sick.
Certainly
in the fall, with our flu season, people around you will be getting sick
and you may get sick.
Be
prepared to stay home for a week or so if you are ill.
Most
people infected with this virus so far have experienced the regular
symptoms of flu (fever, cough, body aches, and a significant number of
people have reported vomiting and diarrhea).
For
people who are critically ill, we do have antiviral medications in our
arsenal against flu.
The
priority use for influenza antiviral drugs at this time is to treat severe
influenza illness.
·Influenza
antiviral drugs are prescription medicines (pills, liquid or an inhaler) with
activity against influenza viruses, including swine influenza viruses.
·There are two
influenza antiviral medications that are recommended for use against swine
influenza. These are oseltamivir (trade name Tamiflu ®) and zanamivir (Relenza
®).
·Influenza
antiviral drugs work best when stated soon after illness onset (within two 2
days), but treatment with antiviral drugs should still be considered after
48 hours of symptom onset, particularly for hospitalized patients or people at
high risk for influenza-related complications.
·You have a role
in protecting yourself and your family.
Stay informed.
Health officials will provide additional information as it becomes
available. Visit www.cdc.gov
Everyone
should take these everyday steps to protect your health and lessen the
spread of this new virus:
Cover your nose and mouth with a tissue when you
cough or sneeze. Throw the tissue in the trash after you use it.
Wash your hands often with soap and water,
especially after you cough or sneeze. Alcohol-based hand cleaners are
also effective.
Avoid touching your eyes, nose or mouth. Germs
spread this way.
Try to avoid close contact with sick people.
If you are sick with a flu-like
illness, stay home for 7 days after your symptoms begin or until you have
been symptom-free for 24 hours, whichever is longer. This is to
keep from infecting others and spreading the virus further.
Follow public
health advice regarding school closures, avoiding crowds and other social
distancing measures.
If
you don¡Çt have one yet, consider developing a family emergency plan as a
precaution.
Here
are a series of links that might be of interest and assistance to you in your
work with health center patients. This information is brought to you as a
result of a new partnership between the National Center for Farmworker Health
and Consumer Reports Best Buy Drugs.
Consumer
Reports has developed a significant presence related to consumer education in
their choices related to prescription drugs. This is the first of a
series of email messages that we will be sending to you on a periodic basis in
hope that this information will be helpful to you, your staff, and your
patients.
Our
assessment of this information is that the literacy level is quite high and
only a limited number of the documents are currently available in Spanish as
well as English. We have already provided CBB with this feedback and they
are working on literacy level adjustment, and translation. So with that
caveat, you may find that this information is most helpful to your staff for
their utilization with patients as a tool in their health education endeavors.
Consumer Reports Best Buy Drugs
A trusted source for
providing independent analysis on the products you buy and use
every day
is now offering a new
public education service.
Consumer
Reports Best Buy Drugs works to empower consumers to make informed
choices on prescription drugs based on effectiveness, safety and price.
Learn about high-quality,
low-cost medicines that will save you thousands of dollars.
Free, unbiased analysis of
drug effectiveness
Best Buy Drugs
provides free reviews conducted by physicians and researchers offering
advice for over 20
drug categories, including our best buy pick for each.
Be informed. Be empowered.
Print free downloadable
guides you can use to talk to your doctor about the most effective and
affordable medicines.
We welcome your input in regard to this and all other emails sent
to you via this e-group. For individual response please direct your
message to me at Ryder@...
We are starting a new project focused on farmworker housing. This new project will begin on August 1, 2009. We need to hire a Project Coordinator and an Associate Project Manager for this new project. I have listed the position descriptions below, as well as included them in an attachment. Please share this announcement with persons who may be interested.
Project Coordinator (Research Associate or Research Instructor)
Department of Family and Community Medicine
WakeForestUniversitySchool of Medicine
We are recruiting a Project Coordinator to participate in a 2-year NIH funded research project.This project will examine housing quality of migrant farmworkers in North Carolina, measure residential environmental hazards experienced by these migrant farmworkers, and determine the association of residential environmental hazards with health outcomes among migrant farmworkers.The research team includes investigators with expertise in dermatology, epidemiology, infectious diseases, medical anthropology, genetics, and environmental health.
Under the direction of the principal investigator, the Project Coordinator will administer the day-to-day operations of the research project.She/he will support the development of data collection materials (in-depth interview guides, survey interview questionnaires, environmental exposure marker protocols, and biomarker protocols).She/he will supervise the recruitment participants for in-depth interviews, and will be expected to participate in the data collection and analysis of these data (using computer-assisted text analysis soft-ware, reading and coding transcripts). She/he will also supervise the recruitment of participants for a survey of housing quality, residential exposure, and health comes.Data collection will be completed over a multi-county region of central North Carolina.Participants will be migrant farmworkers with limited English language skills.The Project Coordinator will participant in training data collectors, supervising data collectors, analyzing data, and disseminating research results.
The position requires regular (weekly) travel to research counties, strong communications and organizational skills, and fluent Spanish-language and English-language skills. A valid driver’s license is required.Rank and salary will be based on the applicant’s education and experience.To be hired at the Research Associate level, the applicant must have an appropriate master’s degree (e.g., MA, MS, MPH, MSW) and research experience; to be hired at the Instructor level, the applicant must have a doctorate degree (e.g., PhD, EdD, DrPH).
We are recruiting an Associate Project Manager to participate in a 2-year NIH funded research project.This project will examine housing quality of migrant farmworkers in North Carolina, measure residential environmental hazards experienced by these migrant farmworkers, and determine the association of residential environmental hazards with health outcomes among migrant farmworkers.The research team includes investigators with expertise in dermatology, epidemiology, infectious diseases, medical anthropology, genetics, and environmental health.
The Associate Project Manager will assist the Project Coordinator in conducting the day-to-day operations of the research project.She/he will support the development of data collection materials (in-depth interview guides, survey interview questionnaires, environmental exposure marker protocols, and biomarker protocols).She/he will participate in the data collection and analysis of in-depth interview data (using computer-assisted text analysis soft-ware, reading and coding transcripts).She/he will provide field supervision of data collectors in a survey of housing quality, residential exposure, and health comes.Data collection will be completed over a multi-county region of central North Carolina.Participants will be migrant farmworkers with limited English language skills.
The position requires extensive and regular (weekly) travel to research counties, and fluent Spanish-language and English-language skills. A valid driver’s license is required.Salary will be based on the applicant’s education and experience.A bachelor’s degree is required, and preference will be given to applicants with a master’s degree (e.g., MA, MS, MPH, MSW).
Here is an email for you from Henry Lopez at the Office of
Migrant and Special Populations, regarding availability of funding for
individuals who might be interested in serving as consultants in evaluation
with the RWJ Foundation.
Bobbi
Bobbi
Ryder
President
& CEO
National
Center for Farmworker Health, Inc.
1770
FM 967
Buda,
TX
(512)
312-5453 direct line
(512)
312-5451 Lisa Mendoza Miller, Assistant
(512)
312-2600
www.ncfh.org
From: Lopez, Henry (HRSA)
[mailto:HLopez@...] Sent: Tuesday, June 16, 2009 11:39 AM To: 'John Lozier'; 'kmountain@...'; 'Bobbi Ryder' Subject: FW: New Connections: $75K grants due July 1 available for
RWJF-related program evaluation
FYI see below....
Henry Lopez, Jr., CAPT, USPHS
Director, Office of Minority & Special Populations
Bureau of Primary Health Care
Health Resources and Service Administration
Health and Human Services
5600 Fishers Lane
Parklawn 16-105
Rockville, Maryland 20857
(301) 594-4303
hlopez@...
From: Perez, Debra J.
[mailto:dperez@...] Sent: Monday, June 15, 2009 3:20 PM To: Perez, Debra J. Cc: Arrington, Edith Subject: New Connections: $75K grants due July 1 available for
RWJF-related program evaluation
Dear Colleague,
I am pleased to announce a new grant opportunity with the
New Connections program at Robert Wood Johnson Foundation (see below and
attached). We recently released the New Connections Call For Proposals (CFP)
for Senior Consultants in Evaluation. We would welcome your assistance in
distributing this CFP to eligible individuals who may be interested in the
opportunity.
An applicant web conference is scheduled for Wednesday,
June 17, 2009 from 3-4:30pm ET- for those interested in getting more
information.
New Connections is a program designed to expand the
diversity of perspectives that inform RWJF programming and introduce new
researchers and scholars to the Foundation. We work with junior
investigators (those who are no more than 7 years from receipt of the doctorate)
and senior consultants (individuals who do not need to have a doctorate but
have at least 10 years of experience) who have been historically
underrepresented in research and evaluation activities supported by RWJF (in
the areas of health and health care). This includes people from ethnic or
racial minority groups, first-generation college graduates and people from
low-income communities.
The 4th round of New Connections for Senior
Consultants is focused on evaluation. Applicants to the New Connections Senior
Consultant CFP must: have at least ten years of evaluation experience; be a
member of a historically underrepresented group (as detailed in the CFP) in
research and evaluation; be a first-time grantee to RWJF; and propose an
evaluation plan for a program related to RWJF team portfolios as listed in the
CFP. Brief proposals are due July 1, 2009.
I have copied our letter of invitation below, for your
information and for you to forward to those individuals who may be interested
in and eligible to apply for the New Connections Senior Consultant CFP. If you
think there is a list serve where this opportunity may be of interest, please
let me know (using the contact information in my signature below) and I will
make contact with the list serve host.
If you have any questions or comments, please do not
hesitate to contact Edith Arrington at earrington@...
or 609) 627-6305.
If you have any questions or need to set up an appointment,
please contact Karen Reuter at kreuter@...
or call 609 627-5954. If you are interested in learning more about
funding opportunities at RWJF please sign up for funding alerts at http://www.rwjf.org/global/signin.jsp
NEW CONNECTIONS: INCREASING DIVERSITY OF RWJF PROGRAMMING
Are you a diverse researcher or evaluator interested
in funding,mentoring and training opportunities?
Do you have at least ten years experience in
evaluation?
If so, the Robert Wood Johnson Foundation’s New Connections:
Increasing Diversity of RWJF Programming is a wonderful opportunity.
Our program offers early-mid career researchers from historically
underrepresented backgrounds funding opportunities, as well as a community
of support, advice, and collaboration. We aim to give diverse researchers
the necessary opportunities to impact change.
Launched in 2005 New Connections is more than a grant
opportunity. It is a life-long professional network for diverse researchers.
To date, New Connections: Increasing Diversity of RWJF Programming has awarded
over $2 million in grants.
We are pleased to announce our Round 4 Call for Proposals
for Senior Consultants.
In this fourth round of call for proposals, New Connections
seeks Senior Consultants who have been underrepresented in research and
evaluation activities and would be first-time grantees to RWJF. This includes
researchers and evaluators who are historically underrepresented ethnic or
racial minorities, first-generation college graduates, and individuals from
low-income communities. Senior Consultants are those who have at least ten
years of experience in research and/or evaluation.
Senior Consultants must propose an evaluation plan for a
project connected to the Building Human Capital and Vulnerable Population
portfolios. Senior Consultants are eligible for a one-year grant of up to
$75,000.
Key Dates:
* Thursday, May 28, 2009 - CFP is released
* Wednesday, June 17, 2009 from 3-4:30pm ET- Optional
applicant web conference
This is an opportunity to answer applicant questions,
and is highly encouraged.
* Wednesday, July 1, 2009 by 3pm ET- Brief Proposal
(8-page concept paper) is due
Please do NOT post this on any list serve. If you have a
colleague that you think would be interested in and eligible for this
opportunity, please forward this email to them. If you think there is a list
serve where this opportunity may be of interest please email us at rwjf-newconnections@... and
New Connections will make contact with the host(s) of the list serve.
See attached: Arcury TA, Grzywacz JG, Chen H, Vallejos QM, Galvan L, Whalley LE, Isom S, Barr DB, Quandt SA. Variation across the agricultural season in organophosphorus pesticide urinary metabolite levels for Latino Farmworkers in eastern North Carolina. American Journal of Industrial Medicine 52:539-550, 2009.
Q&As on the WHO
Declaration of Pandemic Phase 6 for Novel H1N1 Flu as of 11:07am
PHASE
6
What do
the WHO phases mean?
The WHO
phases are based on the geographical spread of a novel influenza virus. As
“pandemic” means worldwide epidemic, a WHO Phase 6 means that the virus is
spreading across the globe. What the WHO phases do NOT do is predict the
severity of the virus.
Using a
hurricane analogy, the WHO phase system simply tells us that a hurricane is
imminent, but it DOES NOT tell us how big or how strong the storm might be.
It is the strength of a hurricane that dictates which pre-landfall actions are
needed, such as just boarding up windows versus a full evacuation. While
weather forecasters can fly an airplane into the eye of a hurricane to measure
a storm’s strength and predict its ultimate severity, there is no such
forecasting tool for flu viruses.
Does WHO’s change to Phase 6 mean the virus is more severe?
No.
It is important to understand that this change is based on the geographic spread of the virus to other
parts of the world and does not necessarily reflect any change in the severity of the virus or associated illness.
So why did WHO move to Phase 6 if the virus severity is unchanged?
The
move to Phase 6 is really an alert that the spread of the H1N1 virus is now
expected to traverse the globe and those nations where the virus has yet to
arrive should expect to eventually see cases and be prepared to respond.
What
does the phase change mean for the United States? What will the U.S. do
differently?
Here in the
United States, the virus has been spreading steadily from person-to-person
since April, so today’s announcement by WHO does not really change what we are
already doing here at home to respond.
In response
to an influenza pandemic, governments, communities, workplaces and individuals
will base the intensity of their efforts to reduce spread of the virus on the
severity of the disease, as reflected by the number of deaths and
hospitalizations from the virus.
The United
States has been responding to the H1N1 flu in a way that balances the health of
our residents while minimizing disruption to society. We will continue to
provide guidance using the most current scientific data available about the
H1N1 flu.
Regardless
of what WHO calls or labels this, we are taking necessary and aggressive
measures to protect the health of our residents out of an abundance of
caution.
What actions has the U.S.
taken already?
Since the first reports of
the appearance of novel H1N1 flu in the U.S., we have been actively and
aggressively implementing our pandemic response plan. We have distributed 11
million courses of antiviral drugs nationwide, we have begun the process of
procuring a vaccine should it be needed, and we have been routinely providing
the latest information to assist health care providers, public health officials
and the public in addressing the challenges posed by this newly-identified
influenza virus.
Is the outbreak over in the U.S.?
The only thing certain
about flu viruses is uncertainty. As we have been saying for some time, we do
expect that we will see more cases, more hospitalizations and more deaths from
this virus. However, to date most people who have become ill with novel H1N1
in the United States have not become seriously ill and have recovered without
hospitalization.
While the
number of cases in the U.S. may be waning, we are continuing to prepare for the
possibility that the virus may return in the fall. We
will continue to watch this virus carefully, especially in the Southern
Hemisphere. Every day we learn more about this virus and its impact on
human health. As we learn new information, we will adjust our responses and
planning, and inform the public and continue to do all we can to make this
outbreak less severe.
Is there
anything individuals can do?
There are everyday common sense things that people must do to protect
their health and lessen the spread of the novel H1N1 virus as well as seasonal
flu viruses. Wash your hands and cover your mouth when you cough or
sneeze. If you are sick, stay home, recover, and keep others
well. Avoid going to work or school. Delay travel plans/. Limit your contact
with others . And stay
informed—be sure to visit www.hhs.gov, www.cdc.gov, and www.pandemicflu.gov
to get the latest information as it becomes available. You can also call 1-800
CDC INFO.
What does Phase 6 mean for vaccine development and production?
First, it
is important to recognize that developing a vaccine for use, in case it is
needed, is different from recommending individuals be immunized. There is a great deal still unknown,
including the severity of illness caused by the virus, how the virus will
evolve, how the outbreak plays out in the coming weeks to months, and what
populations may be most (or least) at risk.
The process
of vaccine preparation is already underway and decisions regarding production
will be informed by what we learn about the need for such a vaccine and what we
learn about the vaccine itself as it is developed and is used in clinical
studies.The goal
is to have vaccine(s) ready, if needed, but this is a multi-step process
and the decisions to have a vaccine ready, if needed, including, potentially,
to produce such vaccines on a large-scale level, is distinct from any decision
to recommend its use.
Are
you planning an H1N1 immunization program?
While we
are all working as fast as possible to develop the vaccine in the event that we
need it, please understand that this is separate from a decision to use it, or
not. Any decisions on immunization programs must be made on the best scientific
and public health evidence available at the time. That said, it is very important
that we prepare expeditiously and thoroughly for all potential scenarios.
---------- Forwarded message
----------
From: CORE CS Community Listserv <cscommunity@...>
Date: 2009/6/11
Subject: WHO Pandemic Phase 6 Announcement - What does this mean? Actionsto
Prepare? Invitation to Phone Q&A Tomorrow June 12 at 11:30-12:30 ET
To: list_cscommunity@...
Dear
Colleagues:
Today
WHO has declared a pandemic and officially moved to Phase 6 in the pandemic
alert scale. This communication and attached document outlines what this means,
what NGOs can and should be doing to prepare, and where to look for additional
and up-to-date information.
The
CORE Group Humanitarian Pandemic Preparedness (H2P) team will host an open
phone line tomorrow, Friday June 12, from 11.30 am-12.30 pm ET for questions
and discussion related to H1N1, pandemic influenza and NGO preparedness and
response. To participate, call:
•
For calls from inside the US, dial toll-free:
1-866-642-1665
•
For calls from outside the US, toll dial: 1-719-387-8317
•
Participant Passcode: 231-747#
What
does this mean?
The WHO declaration of Phase 6 means
that the novel H1N1 strain continues to spread from person-to-person across the
globe. The WHO pandemic alert scale defines a pandemic by the geographic
spread of a novel influenza virus. The alert system does not describe
severity because severity is difficult to define at a global level.
Please find attached a short 1.5 page document on understanding pandemic
severity (from the H2P Community Planning and Response Curriculum).
WHO has said it has good reason to believe that this pandemic, at least in its
early days, will be of moderate severity. That said, the majority of
patients experience mild symptoms (that would be expected in a severe pandemic
as well).
At
the global level, influenza experts will be carefully monitoring the situation
in case the virus begins to cause more severe illness. Flu viruses are
extremely unpredictable and the severity of the situation could change.
WHO is not recommending any restrictions on travel at this time.
At the individual level and in the workplace there is a need for increased
caution. The novel H1N1 strain of flu is a new virus and therefore people
do not have immunity to it. In the workplace, staff should increase
vigilance of workplace sanitation and hygiene (sample posters can be found here and here and here). Also, now more than ever it is important to
enforce that sick employees should stay home and not come to work.
Though
most people who become ill will experience only mild illness, it is important
to note that:
-In some of these countries, around 2% of cases have developed severe
illness, often with very rapid progression to life-threatening pneumonia.
-Most cases of severe and fatal infections have been in adults between
the ages of 30 and 50 years.
-This pattern is significantly different from that seen during epidemics
of seasonal influenza, when most deaths occur in frail elderly people.
-Many, though not all, severe cases have occurred in people with
underlying chronic conditions. Based on limited, preliminary data, conditions
most frequently seen include respiratory diseases, notably asthma,
cardiovascular disease, diabetes, autoimmune disorders, and obesity.
-At the same time, it is important to note that around one third to half
of the severe and fatal infections are occurring in previously healthy young
and middle-aged people.
-Without question, pregnant women are at increased risk of complications.
This heightened risk takes on added importance for a virus, like this one, that
preferentially infects younger age groups.
-Finally, and perhaps of greatest concern, we do not know how this virus
will behave under conditions typically found in the developing world. To date,
the vast majority of cases have been detected and investigated in comparatively
well-off countries.
What actions
should we take to prepare?
We now have an
important window of opportunity to prepare in case the situation becomes more
severe.
1.Internal preparedness planning - Organizations should consider what measures they
would take during a severe pandemic. How would the organization
operate? How can the organization ensure staff safety? How will
communications be handled? How will essential business continuity issues
be addressed?
For
Guidance on Business Continuity Planning, visit these sites:
2.Programmatic preparedness to respond
to the emergency - For organizations that
have the capacity to assist with preparedness activities and/or to respond to
humanitarian needs during a pandemic, an excellent set of global materials has
been developed by the H2P Initiative for working at the national, district and
community level. The materials are available at the CORE Group
and H2P
Initiative websites, and include the H2P Community Planning and Response
Curriculum.
3.Stay informed of the evolving
situation - Visit the sites below, as
well as this
list of recommended websites for the most up-to-date accurate information
as the situation develops:
> For status on the outbreak visit:
A
PowerPoint presentation on Pandemic Influenza: Epidemiology & Mitigation,
History & Current Threat, is now being updated once or twice a week on www.coregroup.org/h2p
(listed as "Pandemic Influenza: Current Threat")
Please
feel free to contact us if you have any questions.
While
it might feel that the issues related to H1 N1 are subsiding…this email from
CDC raises the current level to 6 and declares that a global pandemic is
underway. Please see below.
Any
feedback that you would like to send to me individually should be directed to
me at Ryder@....
Bobbi
Bobbi Ryder
President & CEO
National Center for Farmworker Health, Inc.
1770 FM 967
Buda, TX
(512) 312-5453 direct line
(512) 312-5451 Lisa Mendoza Miller, Assistant
(512) 312-2600
www.ncfh.org
From: Centers for Disease
Control & Prevention [mailto:cdc@...] Sent: Thursday, June 11, 2009 12:07 PM To: ryder@... Subject: Centers for Disease Control and Prevention (CDC) Update
Attached are
updated notes from CDC related to the WHO Declaration of Pandemic Influenza
Phase 6.
On June 11,
2009, the World Health Organization (WHO) raised the worldwide pandemic
alert level to Phase 6.
Designation of
this phase indicates that a global pandemic is underway.
·There are now
community level outbreaks ongoing in other parts of the world.
·State and
international borders don’t matter at this point. The bottom line is that this
new virus is among us all.
·While U.S.
influenza surveillance systems indicate that overall flu activity is decreasing
in the United States, novel H1N1 outbreaks are ongoing in different parts of
the U.S., in some cases with intense activity.
·In the United
States, this virus has been spreading efficiently from person-to-person since
April and, as we have been saying for some time, we do expect that we will see
more cases, more hospitalizations and more deaths from this virus.
·Because there
is already widespread novel H1N1 disease in the United States, the WHO Phase 6
declaration does not change what the United States is currently doing to keep
people healthy and protected from the virus.
·Thus there is
no change to CDC’s recommendations for individuals and communities.
·WHO’s decision
to raise the pandemic alert level to Phase 6 is a reflection of epidemiological
changes in other parts of the world and not a reflection of any
change in the novel H1N1 virus or associated illness.
·At this time,
most of the people who have become ill with novel H1N1 in the United States
have not become seriously ill and have recovered without hospitalization.
·In the United
States, we have been preparing for this for some time.
·And we are
actively and aggressively implementing our pandemic response plan.
Phase
6 is an indicator of spread and not of severity.
·It’s uncertain
at this time how serious or severe this novel H1N1 pandemic will be in terms of
how many people infected have severe complications or death related to novel
H1N1 infection.
There were
three influenza pandemics in the last century and they varied widely in
severity.
The 1918
pandemic killed tens of millions of people.
The 1957
pandemic is thought to have resulted in at least 70,000 deaths in the United
States.
Deaths from
the 1968-69 pandemic were about the same as for seasonal influenza.
This pandemic
certainly poses the potential to be at least as serious as seasonal flu,
if not more so.
Because this
is a new virus, many people will not have immunity to it and illness may
be more severe and widespread as a result.
We are still
learning about this virus and expect that, like all influenza viruses, it
will continue to change.
There are some
encouraging signs:
oSo far we have not seen an extensive pattern of very severe
illness related to this virus.
oResults
of a serology study conducted by CDC suggest that some adults may have some
degree of preexisting cross-reactive antibody to the novel H1N1 flu virus,
especially adults older than 60.
oAnd, this virus does not have the genetic markers for virulence
that we saw in the 1918 pandemic virus, or that we see today in the H5N1 virus
in Asia that has been lethal among people.
·But
it’s early days and too soon to predict what will happen.
·It is important to remember that the potential remains for the
virus to change and cause more severe disease.
·The real
uncertainty is the fall and how the novel H1N1 virus will affect the 2009-2010
influenza season in the United States.
·We are still
learning about the severity and other epidemiological characteristics of the
novel H1N1 virus.
·This
information is important and will be taken into account when making
recommendations with regard to vaccine and other preventive measures in the
fall.
·CDC will update its guidance and recommendations as more
information about the novel H1N1 flu virus becomes available.
·It will
be important that we continue to watch this virus carefully.
·The
Southern Hemisphere is just going into their flu season and how this virus
behaves will give us some clues about what we can expect for the Northern
Hemisphere.
·The
situation is indeed sobering, but it’s important to keep in mind that we are
not helpless.
We are taking action:
The Federal
Government is mounting an aggressive response to this newly declared
pandemic.
CDC’s goals
during this public health emergency are to reduce transmission and illness
severity, and provide information to assist health care providers, public
health officials and the public in addressing the challenges posed by this
newly identified influenza virus.
·Everyday, we
learn more about this virus and what we learn will continue to inform the
actions that we take in response.
·We are
aggressively taking early steps in the vaccine manufacturing process, working
closely with manufacturing and the rest of the government.
·Vaccines are a
very important part of a response to pandemic influenza.
·CDC isolated
the new H1N1 virus, made a candidate vaccine virus, and has provided this virus
to industry so they can begin scaling up for production of a vaccine, if
necessary.
·There are many
steps involved with producing a vaccine and we are committed to going forward
with the NIH, and FDA, BARDA, and the manufacturers of influenza vaccines, to
see about developing full scale vaccine production.
·Where possible,
we are taking parallel steps to speed up the vaccine process.
If
things go well, and we develop a full scale production, it would be
several months until the vaccine were available.
So
vaccine is an important tool for the future.
Public:
So
far, most people who have been ill with this virus have recovered.
We
are monitoring hospitalization and death rates.
At
this point, whether you are tested and actually diagnosed with novel H1N1
is less important than what you do if you become sick.
It’s
possible that this summer, people around you may get sick and you may get
sick.
Certainly
in the fall, with our flu season, people around you will be getting sick
and you may get sick.
Be
prepared to stay home for a week or so if you are ill.
Most
people infected with this virus so far have experienced the regular
symptoms of flu (fever, cough, body aches + a significant number of people
have reported vomiting and diarrhea).
For
people who are critically ill, we do have antiviral medications in our
arsenal against flu.
The
priority use for influenza antiviral drugs at this time is to treat severe
influenza illness.
·Influenza
antiviral drugs are prescription medicines (pills, liquid or an inhaler) with
activity against influenza viruses, including swine influenza viruses.
·There are two
influenza antiviral medications that are recommended for use against swine
influenza. These are oseltamivir (trade name Tamiflu ® and zanamivir (Relenza
®).
·Influenza
antiviral drugs work best when stated soon after illness onset (within two 2
days), but treatment with antiviral drugs should still be considered after
48 hours of symptom onset, particularly for hospitalized patients or people at
high risk for influenza-related complications.
·You have a role
in protecting yourself and your family.
Stay informed.
Health officials will provide additional information as it becomes
available. Visit www.cdc.gov
Everyone
should take these everyday steps to protect your health and lessen the
spread of this new virus:
Cover
your nose and mouth with a tissue when you cough or sneeze. Throw the
tissue in the trash after you use it.
Wash
your hands often with soap and water, especially after you cough or
sneeze. Alcohol-based hand cleaners are also effective.
Avoid
touching your eyes, nose or mouth. Germs spread this way.
Try
to avoid close contact with sick people.
If you are sick with a flu-like illness, stay home for
7 days after your symptoms begin or until you have been symptom-free for
24 hours, whichever is longer. This is to keep from infecting others
and spreading the virus further.
Follow public
health advice regarding school closures, avoiding crowds and other social
distancing measures.
If you don’t
have one yet, consider developing a family emergency plan as a
precaution.
Pandemic Severity, General
·Influenza
pandemics can range in severity, mainly in terms of the number of people that
have severe illness and die.
·Pandemic
severity may also change over time and will differ across regions of the world,
in different countries and even within different communities within a country.
·Pandemic
disease severity will vary depending on several factors: a nation’s ability to
provide health care to their people, the availability of antiviral medications
to treat those who are sick, differences in how the disease affects people in
different age groups, and the effectiveness of efforts to reduce
person-to-person transmission of influenza.
·An
evaluation of pandemic severity should be based on local circumstances for this
reason.
·A
pandemic severity index helps pubic health officials to match the timing of the
spread and severity of the outbreak with the appropriate use of public health
and community resources to minimize the number of people who get sick and the
number of people who die.
U.S. Pandemic Severity Index (PSI)
CDC developed
the U.S. Pandemic Severity Index (PSI) to describe the severity of a
pandemic in terms of illness and death.
The U.S. PSI
scale is based on the case-fatality ratio; the likelihood of people dying
from the disease.
The PSI scale
ranges from Category 1 to Category 5 and is comparable to the U.S.
hurricane severity index.
Category 1 is
the least severe and Category 5 is the most severe.
Excess death
rate of less than 30 per 100,000 people
Illness rate
of 20-40% of the population
Less than
90,000 potential deaths (based on 2006 U.S. population)
Similar to a
more severe seasonal flu year in the United States
A category 2
pandemic has the following:
§Case
fatality ratio of 0.1 percent to less than 0.5 percent.
§Between
90,000 and 450,000 deaths in the U.S. (based on 2006 U.S. population)
§Excess
death rate of between 30 to less than 150 per 100,000 people
§Illness
rate of between 20 and 40 percent.
§Similar
to 1957 pandemic.
A category 5
pandemic has the following:
Case
fatality ratio of greater or equal to 2 percent
Excess death
rate of more than 600 per 100,000 people
Illness rate
of 20-40% of the population
Greater than
or equal to 1.8 million potential deaths (based on 2006 U.S. population)
Similar to
the 1918 pandemic
The importance of identifying a
category of severity is only to help guide the public health interventions
recommended for individuals and communities.
The PSI scale
helps public health officials match the range of public health
intervention efforts to the severity of a pandemic.
For
a Category 1 to 3 pandemic:
Ill adults
and children are asked to stay home voluntarily.
If someone
in the household is sick, well adults and children do not need to
stay at home.
School and
child care dismissal is not generally recommended, but may be considered
depending on the local impact of the disease.
Workplace and Community adult social distancing
efforts (e.g., encouraging teleconferences instead of meetings, reducing
density, meaning the number of people crowded into an enclosed space, in
public transit and the workplace, postponing or canceling selected
public gatherings, encouraging people to telework, or take staggered
shifts) are generally not recommended.
For a
Category 4 to 5 pandemic
Ill adults
and children are asked to stay home voluntarily.
If someone
in the household is sick, well adults and children should stay at home
too.
School and
child care dismissal is recommended for up to 12 weeks.
Workplace and Community adult social distancing
efforts (e.g., encouraging teleconferences instead of meetings, reducing
density, meaning the number of people crowded into an enclosed space, in
public transit and the workplace, postponing or canceling selected
public gatherings, encouraging people to telework, or take staggered
shifts) are recommended
Declaration of Phase 6 and Travel
At this time,
CDC does not recommend against travel to any country.
CDC will
continue to monitor the H1N1 situation around the world and will provide
recommendations to U.S. travelers based on the changing situation.
Travelers
should check the CDC travelers’ health website (www.cdc.gov/travel) for
information related to this outbreak, as well as for health information on
the prevention and management of flu.
Travelers
should also check the website of the embassy of the country to which they
are traveling for the latest updates on entry or exit screening procedures
which may impact their travel.
CDC recommends
that ill persons postpone travel both for their protection and that of
other travelers.
·The
World Health Organization (WHO) has developed a plan to be prepared for a
global outbreak of influenza to help countries to protect the public’s health
before and during a pandemic.
·This
plan defines the “phases” of a pandemic which describe the global risk for a
pandemic and the extent of global spread.
·The
WHO phases provide a benchmark to guide national preparedness and planning for
a pandemic, and helps to indicate when countries should shift to response and
mitigation efforts.
·The
WHO phases are:
oPhase
1:
No new influenza virus subtypes have been detected in humans. An influenza
virus subtype that has caused human infection may be present in animals. If
present in animals, the risk of human infection or disease is considered to be
low.
oPhase
2:
No new influenza virus subtypes have been detected in humans. However, an
animal influenza virus circulating among domesticated or wild animals is known
to have caused infection in humans and poses a substantial risk of human
disease.
oPhase
3:
An animal or human-animal influenza reassortant virus has caused sporadic cases
or small clusters of disease in people, but has not resulted in human-to-human
transmission sufficient to sustain community-level outbreaks. Human
infection(s) that occur with this new subtype occur with at most rare inst
ances of human-to-human spread, or spread to a close contact.
oPhase
4:
Small cluster(s) of human infections with limited but verified human-to-human
transmission. The spread is highly localized, suggesting that the virus is not
well adapted to humans. However, the virus has the potential to cause
“community-level outbreaks.
oPhase
5:
There is human-to-human spread of the virus into at least two countries in one
WHO region. Most countries are not affected but there are larger though
localized cluster(s) of human infections due to human-to-human spread. These
changes suggest that the vir us is becoming increasingly better adapted to
humans. There is a substantial pandemic risk.
oPhase
6:
The pandemic phase. There is increased and sustained transmission with
community level outbreaks in at least one other country in a second WHO region.
This phase indicates that a global pandemic is under way.
WHO Phase 6 Declaration
• The World Health
Organization (WHO) has declared Pandemic Phase 6; that this outbreak of
influenza is a pandemic, which means that the current novel H1N1 flu which is
spreading involves sustained human-to-human transmission in two or more regions
of the world.
• Because there is already
widespread novel H1N1 flu virus disease in the United States, the WHO Phase 6
declaration does not change what the United States is currently doing to keep
people healthy and protected from the virus.
·Thus
there is no change to CDC’s recommendations for individuals and communities.
• CDC’s initial
recommendations were aimed at preventing and minimizing illness and death in
light of uncertainty about the how severe novel H1N1 flu would be.
• It is important to remember
that the potential remains for the virus to change and cause more severe
disease.
CDC will
update its guidance and recommendations as more information about the
novel H1N1 flu virus becomes available.
Significance of WHO Phase 6
Declaration – [Moderate] Severity Index
WHO has a
three point scale to determine pandemic severity – mild, moderate and
severe.
At this time,
WHO has indicated this seems to be a moderately severe pandemic.
The WHO
severity index advises countries about the possible impact on health and
other related issues as a result of the current novel H1N1 flu
outbreak.
Similar to how
on any given day the weather pattern and the severity of weather will
differ from country to country around the world and even within a country,
the novel H1N1 flu pandemic will affect countries and communities in
different ways.
• The effects of the novel
H1N1 flu pandemic will not be the same for all countries, and countries may not
experience effects at the same time.
Transmission
of the novel H1N1 virus from person to person will affect countries at
different times of the year but also in different locations within these
countries.
The potential
health effects of the influenza pandemic will differ depending on several
factors: a nation’s ability to provide health care to their people, the
availability of antiviral medications to treat those who are sick,
differences in how the disease affects people in different age groups, and
the effectiveness of efforts to reduce person-to-person transmission of
influenza.
As
understanding of the novel H1N1 virus becomes clearer over time, the WHO
recommendations may change. CDC will remain flexible in order to respond
in the best way possible to the changing situation and provide updated
guidance as more information becomes available.
Check national center for farmworker health. They have the most upto date
information.
--- In migrant_health_research@yahoogroups.com, Fiorella Horna-Guerra
<fiorella.horna-guerra@...> wrote:
>
> Hello Everyone, I am hoping you may be able to help me identify rural
> health programs at universities or Area Health Education Centers in the
> following states,
>
> California
>
> Connecticut
>
> Delaware
>
> Maine
>
> New York
>
> North Carolina
>
> Rhode Island
>
> Texas
>
>
> I am a Rural Health Fellow for the National Association of Rural Health
> and our assignment is to gather information about these programs to
> enter into a searchable database that will be available online for the
> general public, particularly for those following a career track in
> health and healthcare delivery.
>
> All and any information is greatly appreciated.
> If you have any questions, please do not hesitate to contact me.
> Thank you sooo very much!
> ~ fiorella
>
> --
> Fiorella Horna-Guerra, Program Consultant
> North Carolina Farmworker Health Program
> Office of Rural Health and Community Care, NC DHHS
> 2009 Mail Service Center ° Raleigh, NC 27699
> (919) 733-2040 main ¦ (919) 733-2981 fax
> www.ncfhp.org <http://www.ncfhp.org>
>
> /"/If you love something, set it free. If it comes back to you, it's
> yours. If it doesn't, it never was///."/
> Author Unknown
>
> --
> This message and accompanying documents are covered by the Electronic
> Communications Privacy Act, 18 U.S.C. §§ 2510-2521, and contain
> information intended for the specified individual(s) only. This
> information is confidential. If you are not the intended recipient or
> an agent responsible for delivering it to the intended recipient, you
> are hereby notified that you have received this document in error and
> that any review, dissemination, copying, or the taking of any action
> based on the contents of this information is strictly prohibited. If you
> have received this communication in error, please notify us immediately
> by e-mail, and delete the original message.
>
Of particular interest is the model of telemedicine
mentioned here:
The Oaxacan Indians, mistrustful of doctors, rely heavily on
home remedies and refrain from seeking treatment of serious illness or injury.
That problem has led Mr. López to spearhead a project in
which Oaxacan doctors give medical advice in Mixteco by videoconference to
immigrants at clinics in the Central Valley.
The Oaxacan government is collaborating on the project, and the Center for
Reducing Health Disparities at the University
of California, Davis, Health System is the lead organizer.
Is anyone
familiar with this project or involved in it? I’d be very interested in
learning more.
School of Rural Public Health, Texas A&M University System
Health Science Center
From:
migrant_health_research@yahoogroups.com
[mailto:migrant_health_research@yahoogroups.com] On Behalf Of Fiorella
Horna-Guerra Sent: Tuesday, June 02, 2009 11:57 AM To: migrant_health_research@yahoogroups.com Subject: [migrant_health_research] Rural Health Programs
Hello Everyone, I am hoping you may be able to help me identify rural health
programs at universities or Area Health Education Centers in the following
states,
California
Connecticut
Delaware
Maine
New York
North Carolina
Rhode Island
Texas
I am a Rural Health Fellow for the National Association of Rural Health and our
assignment is to gather information about these programs to enter into a
searchable database that will be available online for the general public,
particularly for those following a career track in health and healthcare
delivery.
All and any information is greatly appreciated.
If you have any questions, please do not hesitate to contact me.
Thank you sooo very much!
~ fiorella
-- Fiorella
Horna-Guerra, Program Consultant North Carolina Farmworker Health Program
Office of Rural Health and Community Care, NC DHHS
2009 Mail Service Center ° Raleigh, NC 27699
(919) 733-2040 main ¦ (919) 733-2981 fax www.ncfhp.org
"If you love something, set it free. If
it comes back to you, it's yours. If it doesn't, it never was."
Author Unknown
-- This message and
accompanying documents are covered by the Electronic Communications
Privacy Act, 18 U.S.C. §§ 2510-2521, and contain information intended for the
specified individual(s) only. This information is confidential. If you are not
the intended recipient or an agent responsible for delivering it to the
intended recipient, you are hereby notified that you have received this
document in error and that any review, dissemination, copying, or the taking of
any action based on the contents of this information is strictly prohibited. If
you have received this communication in error, please notify us immediately by
e-mail, and delete the original message.
Hello Everyone, I am hoping you may be able to help me identify rural
health programs at universities or Area Health Education Centers in the
following states,
California
Connecticut
Delaware
Maine
New York
North
Carolina
Rhode Island
Texas
I am a Rural Health Fellow for the National Association of Rural Health
and our assignment is to gather information about these programs to
enter into a searchable database that will be available online for the
general public, particularly for those following a career track in
health and healthcare delivery.
All and any information is greatly appreciated.
If you have any questions, please do not hesitate to contact me.
Thank you sooo very much!
~ fiorella
-- ncfhpsigFiorella
Horna-Guerra, Program Consultant North
Carolina
Farmworker Health Program Office of Rural Health and Community
Care, NC DHHS 2009 Mail Service Center ° Raleigh, NC 27699 (919) 733-2040 main ¦ (919) 733-2981 fax www.ncfhp.org
"If you love
something, set it free.
If it comes back to you, it's yours.
If it doesn't, it never was."
Author Unknown
--
This message and accompanying
documents are covered
by the Electronic Communications Privacy Act, 18 U.S.C. §§
2510-2521, and contain information intended for the specified
individual(s) only. This information is confidential. If you are not
the intended recipient or an agent responsible for delivering it
to the intended recipient, you are hereby notified that you have
received this document in error and that any review,
dissemination, copying, or the taking of any action based on the
contents of this information is strictly prohibited. If you have
received this communication in error, please notify us immediately by
e-mail, and delete the original message.